VeriMomIst s-spider oligopeptide-1 in der Schwangerschaft sicher?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety finding for oligopeptide-1/EGF; no human teratogenic data. Peptides such as EGF are large biomolecules with low expected dermal penetration and no published reproductive hazard signals in regulatory sources or the peer-reviewed literature searched (PubMed). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard publications), CosIng/PubChem (ingredient identity and peptide nature).
Related ingredients
Frequently asked questions
- Ist s-spider oligopeptide-1 in der Schwangerschaft sicher?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety finding for oligopeptide-1/EGF; no human teratogenic data. Peptides such as EGF are large biomolecules with low expected dermal penetration and no published reproductive hazard signals in regulatory sources or the peer-reviewed literature searched (PubMed). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard publications), CosIng/PubChem (ingredient identity and peptide nature).
- Ist s-spider oligopeptide-1 während des Stillens sicher?
- No regulatory or peer-reviewed evidence of reproductive or lactation-specific hazards for oligopeptide-1/EGF. As a peptide with low systemic absorption from topical use, there is no demonstrated mechanism or data indicating transfer into breast milk or lactation-related effects in mother or infant. Sources: CIR/SCCS databases (no adverse findings), PubMed (no lactation transfer data indicating hazard), CosIng.
- Ist s-spider oligopeptide-1 sicher für Babyhaut?
- Hazard and mechanism: no evidence of developmental or reproductive toxicity specific to infants. Exposure: while adult dermal absorption is expected to be negligible for a large peptide (adult e=0), infant skin has higher surface-area-to-weight and an immature barrier so exposure is plausibly higher; therefore exposure score increased by +1 to e=1 for 0–3 yr skin. No infant-specific adverse data were identified in PubMed or regulatory sources. Sources: PubMed (no infant toxicity reports), CosIng, ECHA (no harmonised classification).
- Wie bewertet VeriMom s-spider oligopeptide-1?
- VeriMom bewertet s-spider oligopeptide-1 mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu s-spider oligopeptide-1?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu s-spider oligopeptide-1 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.